2,007
Participants
Start Date
October 8, 2007
Primary Completion Date
June 10, 2008
Study Completion Date
June 10, 2008
GlaxoSmithKline Biologicals' influenza vaccine GSK576389A
Single dose, Intramuscular injection, 8 different formulations were tested (one per group)
Fluarix
Single dose, Intramuscular injection
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Hamburg
GSK Investigational Site, Hamburg
GSK Investigational Site, Magdeburg
GSK Investigational Site, Wolmirstedt
GSK Investigational Site, Essen
GSK Investigational Site, Cologne
GSK Investigational Site, Mainz
GSK Investigational Site, Rhaunen
GSK Investigational Site, Mannheim
GSK Investigational Site, Weinheim
GSK Investigational Site, Rudersberg
GSK Investigational Site, Güglingen
GSK Investigational Site, Augsburg
GSK Investigational Site, Dresden
GSK Investigational Site, Freital
GSK Investigational Site, Leipzig
GSK Investigational Site, Rotterdam
GSK Investigational Site, Rotterdam
GSK Investigational Site, Eskilstuna
GSK Investigational Site, Karlskrona
GSK Investigational Site, Uppsala
GSK Investigational Site, Reading
GSK Investigational Site, Buckshaw Village, Chorley
GSK Investigational Site, Clydebank, Glasgow
GSK Investigational Site, Edgbaston, Birmingham
GSK Investigational Site, Waterloo, Liverpool
Lead Sponsor
GlaxoSmithKline
INDUSTRY